Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma (2018)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s12072-018-9909-3
PubMed Identifier: 30467624
Publication URI: http://europepmc.org/abstract/MED/30467624
Type: Journal Article/Review
Parent Publication: Hepatology International
Issue: 1
ISSN: 1936-0533